Thrombin-induced exposure and prostacyclin inhibition of the receptor for factor VIII/von Willebrand factor on human platelets

scientific article published on June 1, 1982

Thrombin-induced exposure and prostacyclin inhibition of the receptor for factor VIII/von Willebrand factor on human platelets is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1172/JCI110560
P953full work available at URLhttps://europepmc.org/articles/PMC370193
http://www.jci.org/articles/view/110560/files/pdf
https://europepmc.org/articles/PMC370193?pdf=render
P932PMC publication ID370193
P698PubMed publication ID6282932

P50authorJacek J. HawigerQ88341029
P2093author name stringT. Fujimoto
J. Hawiger
S. Ohara
P2860cites workProtein measurement with the Folin phenol reagentQ20900776
Diffusion-in-gel methods for immunological analysisQ28183578
Studies of the mechanism of the human platelet release reaction induced by immunologic stimuli. III. Relationship between the binding of soluble IgG aggregates to the Fc receptor and cell response in the presence and absence of plasmaQ28329782
Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxidesQ28330215
The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresisQ29053311
Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's diseaseQ33332522
Binding of Factor VIII to Platelets in the Presence of RistocetinQ33445370
IN VIVO BEHAVIOR OF I-FIBRINOGEN.Q33943912
Platelet receptors for human Factor VIII/von Willebrand protein: functional correlation of receptor occupancy and ristocetin-induced platelet aggregationQ34039151
Inhibition of human platelet aggregation by monovalent antifibrinogen antibody fragmentsQ34480048
???Q64800736
Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen contentQ34512731
Synthesis of prostaglandin I2 (prostacyclin) by cultured human and bovine endothelial cellsQ35051655
Interaction of coagulation factor Xa with human plateletsQ35053163
The effects of thrombin on adenyl cyclase activity and a membrane protein from human plateletsQ35896881
The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activityQ35905116
The measurement of thrombin in clotting blood by radioimmunoassayQ35905215
Immunoinhibition of ristocetin-induced platelet aggregationQ35905523
The effects of thrombin on phytohemagglutinin receptor sites in human plateletsQ36196195
Demonstration and characterization of specific binding sites for factor VIII/von Willebrand factor on human plateletsQ37037311
Staphylococci-induced Human Platelet Injury Mediated by Protein A and Immunoglobulin G Fc Fragment ReceptorQ37042197
The hemostatic plugQ39625527
Platelet Adherence to the Vessel Wall and to Collagen-Coated SurfacesQ39770088
Modulation of human platelet adenylate cyclase by prostacyclin (PGX)Q40061238
Stimulation of calcium uptake in platelet membrane vesicles by adenosine 3′,5′-cyclic monophosphate and protein kinaseQ40063660
Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in plateletsQ40093715
Action of thrombin on surface glycoproteins of human plateletsQ40202953
Relationship of sialic acid to function and in vivo survival of human factor VIII/von Willebrand factor proteinQ40651808
Studies on the mechanism of ristocetin-induced platelet agglutination: binding of ristocetin to plateletsQ40706596
Comparison of factor VIII-related von Willebrand factor proteins prepared from human cryoprecipitate and factor VIII concentrateQ40711333
Generation of prostacyclin by lungs in vivo and its release into the arterial circulationQ40902833
Prostacyclin (prostaglandin I2, PGI2) inhibits platelet adhesion and thrombus formation on subendotheliumQ40989621
Fibrinogen heterogeneity in human plasma. Electrophoretic demonstration and characterization of two major fibrinogen components.Q53953896
Cyclic nucleotides in platelet functionQ66849362
Studies on the Mechanism of Ristocetin-induced Platelet Aggregation: Binding of Factor VIII to PlateletsQ66971029
Separation of human platelets from plasma proteins including factor VIIIVWF by a combined albumin gradient-gel filtration method using hepes bufferQ67313242
Platelet plasma membrane glycoproteins. Identification of a proteolytic substrate for thrombinQ67573793
Binding of soluble form of fibroblast surface protein, fibronectin, to collagenQ67675651
Equilibrium binding of thrombin to plateletsQ67861772
Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping testQ68448125
Decreased adhesion of platelets to subendothelium in von Willebrand's diseaseQ69125425
Selective binding of the factor VIII/von Willebrand factor protein to human plateletsQ72072837
Exposure of fibrinogen receptor on human platelets by proteolytic enzymesQ72876006
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectplatelet membrane glycoproteinsQ7202248
P304page(s)1212-1222
P577publication date1982-06-01
P1433published inJournal of Clinical InvestigationQ3186904
P1476titleThrombin-induced exposure and prostacyclin inhibition of the receptor for factor VIII/von Willebrand factor on human platelets
P478volume69

Reverse relations

cites work (P2860)
Q67675819A conformation-dependent epitope of human platelet glycoprotein IIIa
Q37562150ADP-dependent common receptor mechanism for binding of von Willebrand factor and fibrinogen to human platelets
Q33478418Abnormalities of factor VIII related protein multimers in the haemolytic uraemic syndrome
Q37711758Adhesive interactions of platelets and their blockade
Q34521638Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation
Q39758344Cell biology of endothelial cells
Q36413864Cloning and characterization of two cDNAs coding for human von Willebrand factor.
Q35585012Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon
Q77486580Elevation of cyclic AMP decreases phosphoinositide turnover and inhibits thrombin-induced secretion in human platelets
Q70201984Evidence that three adhesive proteins interact with a common recognition site on activated platelets
Q39478807Factor VIII/von Willebrand factor: a multivalent ligand binding to platelets and collagen
Q34564820Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate
Q56601465Formation and regulation of platelet and fibrin hemostatic plug
Q34528200Functionally thrombasthenic state in normal platelets following the administration of ticlopidine
Q36314768Glanzmann thrombasthenia: deficient binding of von Willebrand factor to thrombin-stimulated platelets
Q43146191Identification of amino acid residues responsible for von Willebrand factor binding to sulfatide by charged-to-alanine-scanning mutagenesis
Q34565552Independent modulation of von Willebrand factor and fibrinogen binding to the platelet membrane glycoprotein IIb/IIIa complex as demonstrated by monoclonal antibody
Q71943871Influence of ionized calcium on thrombin-induced down regulation of GPIb/IX receptors on human platelets
Q30654069Influence of thrombin in suspension, surface activation, and high shear on platelet surface GPIb/IX distribution.
Q41559907Inhibition of von Willebrand factor–platelet interaction by fibrinogen
Q37554183Interaction of purified type IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation
Q34602783Interaction of von Willebrand factor with human platelets in the plasma milieu
Q38737720Molecular cloning, expression and assembly of multimeric von Willebrand factor
Q39592850Molecular pathology and immunology of factor VIII (hemophilia A and factor VIII inhibitors).
Q44408524Novel effect of cyclicization of the Arg-Gly-Asp-containing peptide on vitronectin binding to platelets
Q40559317Pharmacology of current and future antithrombotic therapies.
Q39836539Physiologic functions of normal endothelial cells
Q34619713Platelet interaction with rabbit subendothelium in von Willebrand's disease: altered thrombus formation distinct from defective platelet adhesion
Q33821754Platelets have more than one binding site for von Willebrand factor
Q36265236Potentiation of alpha 1-adrenergic responses in rat liver by a cAMP-dependent mechanism
Q28267439Role of plasma, platelets, and endothelial cells in tumor metastasis
Q67292167Role of von Willebrand factor in platelet adhesion to the subendothelium
Q72592797Specific binding of blood coagulation factor XIIIa to thrombin-stimulated platelets
Q30942858Sulfatides partition disabled-2 in response to platelet activation
Q37556824The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets
Q39591751The physiology and pathophysiology of the factor VIII complex
Q41517769The platelet fibrinogen receptor: an immunogold-surface replica study of agonist-induced ligand binding and receptor clustering
Q40159483Time and force dependence of the rupture of glycoprotein IIb-IIIa-fibrinogen bonds between latex spheres
Q77696574Two-stage activation for alpha5beta1 integrin binding to surface-adsorbed fibronectin
Q40347050Vitronectin binds to activated human platelets and plays a role in platelet aggregation
Q36220351Von Willebrand factor promotes endothelial cell adhesion via an Arg-Gly-Asp-dependent mechanism
Q33444536Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor
Q67276057von Willebrand disease
Q70321843von Willebrand disease
Q37711736von Willebrand factor and platelet function
Q38687794von Willebrand factor and platelet function
Q33478102von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease
Q34574601von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia
Q34544068von Willebrand protein facilitates platelet incorporation in polymerizing fibrin

Search more.